IRIS
MAZZOCCA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.749
AS - Asia 2.026
EU - Europa 1.359
SA - Sud America 436
AF - Africa 72
OC - Oceania 12
AN - Antartide 1
Totale 8.655
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.683
SG - Singapore 798
CN - Cina 501
BR - Brasile 340
IT - Italia 257
HK - Hong Kong 241
SE - Svezia 234
RU - Federazione Russa 199
VN - Vietnam 179
DE - Germania 177
FR - Francia 127
FI - Finlandia 96
GB - Regno Unito 83
IN - India 61
UA - Ucraina 59
BD - Bangladesh 36
IQ - Iraq 33
CA - Canada 30
NL - Olanda 29
AR - Argentina 27
ID - Indonesia 26
MX - Messico 24
SA - Arabia Saudita 22
ZA - Sudafrica 21
EC - Ecuador 20
BE - Belgio 18
ES - Italia 18
PK - Pakistan 17
PL - Polonia 16
VE - Venezuela 15
TR - Turchia 14
CI - Costa d'Avorio 13
CO - Colombia 12
AU - Australia 11
JP - Giappone 11
PH - Filippine 11
LB - Libano 9
LT - Lituania 9
AT - Austria 8
EG - Egitto 8
IE - Irlanda 8
UZ - Uzbekistan 8
IR - Iran 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
MY - Malesia 6
NP - Nepal 6
KE - Kenya 5
MA - Marocco 5
PA - Panama 5
PE - Perù 5
UY - Uruguay 5
BH - Bahrain 4
BO - Bolivia 4
CL - Cile 4
JO - Giordania 4
OM - Oman 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
PY - Paraguay 3
RO - Romania 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IL - Israele 2
KR - Corea 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
HR - Croazia 1
KI - Kiribati 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MU - Mauritius 1
MV - Maldive 1
MW - Malawi 1
MZ - Mozambico 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 8.654
Salva come PNG Salva come JPEG
Città #
Ashburn 546
Fairfield 529
Woodbridge 443
Singapore 424
Houston 340
Chandler 329
Seattle 241
Hong Kong 237
Nyköping 192
Cambridge 190
Wilmington 182
San Jose 178
Jacksonville 157
Ann Arbor 150
Beijing 137
Bari 94
Dallas 86
Los Angeles 77
Lauterbourg 71
Lawrence 63
Roxbury 62
New York 61
Ho Chi Minh City 58
Nanjing 56
Des Moines 43
Helsinki 40
Hanoi 36
Santa Clara 36
Brooklyn 35
Inglewood 31
North Bergen 30
Princeton 29
Munich 26
Buffalo 24
Boardman 23
Dearborn 22
Shenyang 21
Council Bluffs 20
São Paulo 20
Brussels 17
San Diego 17
Dong Ket 16
Falkenstein 16
London 16
Frankfurt am Main 15
Guangzhou 15
Jakarta 15
Jiaxing 15
Milan 15
Nanchang 15
Nuremberg 15
Rio de Janeiro 15
Chicago 14
Abidjan 13
Hebei 13
Paris 13
Baghdad 12
Mumbai 12
Riyadh 12
Zhengzhou 12
Moscow 11
Orem 11
Toronto 11
Eindhoven 10
Haiphong 10
Hangzhou 10
Jinan 10
Mexico City 10
Tokyo 10
Boston 9
Changsha 9
Montreal 9
Ningbo 9
Ostuni 9
San Francisco 9
San Mateo 9
The Dalles 9
Tianjin 9
Warsaw 9
Belo Horizonte 8
Da Nang 8
Dublin 8
Johannesburg 8
Norwalk 8
Chennai 7
Dhaka 7
Leawood 7
Porto Alegre 7
Redwood City 7
Stockholm 7
Taizhou 7
Tashkent 7
Turku 7
Ardabil 6
Atlanta 6
Cairo 6
Columbus 6
Guayaquil 6
Jeddah 6
Mottola 6
Totale 5.970
Salva come PNG Salva come JPEG
Nome #
Autotaxin is a novel molecular identifier of type I endometrial cancer 202
Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma 190
Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D 173
T(14;18) translocation in chronic hepatitis C virus infection 173
A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells 172
Circulating levels of PAI-1 and SERPINE1 4G/4G polymorphism are predictive of poor prognosis in HCC patients undergoing TACE 170
Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology 168
Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells 165
Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts 164
Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment 162
Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide. 151
ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer 149
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 148
Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer 148
Topology of the mitochondrial cAMP-dependent protein kinase and its substrates 142
Clinical Usefulness of Cancer Antigen 15-3 in Breast Cancer Patients Before and After Surgery 141
A systemic evolutionary approach to cancer: Hepatocarcinogenesis as a paradigm 141
Moving the systemic evolutionary approach to cancer forward: Therapeutic implications 137
cAMP-dependent protein kinase of mitochondria. Structure and possible role of the substrates 134
Topology of the mitochondrial cAMP-dependent protein kinase and its substrates 131
null 131
Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease 131
Sorafenib: 10 years after the first pivotal trial 125
Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration 124
A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions 122
PI3K Functions in Cancer Progression, Anticancer Immunity and Immune Evasion by Tumors 119
Pathobiology of Hepatocellular Carcinoma and Clinical Impact 119
Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L 117
1H-NMR metabolomics reveals a multitarget action of Crithmum maritimum ethyl acetate extract in inhibiting hepatocellular carcinoma cell growth 117
Frictional purpuric eruption associated with angiotensin II receptor blockers 116
Sorafenib: The gold standard therapy in advanced hepatocellular carcinoma and beyond 116
Tetraspanin CD81-Regulated Cell Motility Plays a Critical Role in Intrahepatic Metastasis of Hepatocellular Carcinoma 116
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. 113
The integrin, α6β1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells 113
Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro 112
Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells 111
Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer 111
Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance 109
The metastatic process: methodological advances and pharmacological challenges 108
Crithmum maritimum Extract Restores Lipid Homeostasis and Metabolic Profile of Liver Cancer Cells to a Normal Phenotype 107
Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link? 105
Tetraspanin-enriched microdomains and hepatocellular carcinoma progression. 104
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. 103
cAMP-dependent protein kinase of mitochondria structure and possible role of the substrates 101
cAMP-dependent protein kinase of mitochondria structure and possible role of the substrates 97
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC 97
A multicomponent personalized prevention program in the primary care setting: a randomized clinical trial in older people with noncommunicable chronic diseases (Primacare_P3 study) 96
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function 96
The TGF-β signaling pathway as a pharmacological target in hepatocellular carcinoma 92
Cellular Adaptation Takes Advantage of Atavistic Regression Programs during Carcinogenesis 91
Hepatocellular carcinoma progression is accelerated by cancer associated fibroblasts stimulated by tumor production of lysophosphatidic acid 91
Tetraspanins CD9 and CD81 are molecular partners of trimeric FcεRI on human antigen-presenting cells 91
Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer 91
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study 90
Growth inhibition by the farnesyltransferase inhibitor FTI-277 involves Bcl-2 expression and defective association with Raf-1 in liver cancer cell lines 90
Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infection 90
The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer. 89
Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer 89
Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth 88
Synergism of adipocytokine profile and ADIPOQ/TNF-α polymorphisms in NAFLD-associated mets predict colorectal liver metastases outgrowth 87
Inhibiting TGF-β signaling in hepatocellular carcinoma 83
Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans 80
Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation 78
Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline-deficient l-amino acid-defined diet prevents hepatocarcinogenesis in mice 77
Hepatic osteodystrophy in elderly: role of insulin-like growth factor-I and osteocalcin 77
Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma 76
PI3K class 1B controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma 75
Effect of change of interleukin-6 over time on gait speed response: Results from the lifestyle interventions and independence for elders study 74
Crithmum maritimum Improves Sorafenib Sensitivity by Decreasing Lactic Acid Fermentation and Inducing a Pro-Hepatocyte Marker Profile in Hepatocellular Carcinoma 71
Characterization of circulating endothelial cells in Hereditary Haemorrhagic Telangiectasia 69
Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma 67
Targeting TGF-βRI inhibits activation of β1 integrin and blocks vascular invasion in Hepatocellular Carcinoma (HCC) 67
Implications of the lysophosphatidic acid signaling axis in liver cancer 67
Treatment of liver cancer cells with ethyl acetate extract of Crithmum maritimum permits reducing sorafenib dose and toxicity maintaining its efficacy 66
Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis 64
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy 64
The Edible Plant Crithmum maritimum Shows Nutraceutical Properties by Targeting Energy Metabolism in Hepatic Cancer 57
The perplexity of targeting genetic alterations in hepatocellular carcinoma 56
Dysfunctional mitochondrial bioenergetics sustains drug resistance in cancer cells 55
Microenvironmental stress drives tumor cell maladaptation and malignancy through regulation of mitochondrial and nuclear cytochrome c oxidase subunits 50
Lipotoxicity of palmitic acid is associated with DGAT1 downregulation and abolished by PPARα activation in liver cells 49
Chronic Inflammation in Obesity and Cancer Cachexia 29
The systemic evolutionary theory of the origin of cancer (SETOC): an update 28
Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells 25
DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer 23
The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance 21
New hypotheses for cancer generation and progression 14
The Systemic-Evolutionary Theory of the Origin of Cancer (SETOC): A New Interpretative Model of Cancer as a Complex Biological System 10
Totale 8.948
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.833
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.833
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021243 0 0 0 0 0 0 0 0 0 118 78 47
2021/2022485 17 61 5 15 34 30 28 26 34 24 93 118
2022/2023814 122 107 68 66 94 95 10 99 109 4 30 10
2023/2024240 23 51 14 28 18 55 8 8 1 7 11 16
2024/20251.441 21 14 97 50 47 108 183 109 117 63 189 443
2025/20262.827 465 123 244 387 367 151 349 114 336 291 0 0
Totale 8.948